GLP-1 Patient Assistance Programs: The Complete 2026 Guide

Manufacturer patient assistance programs (PAPs) are the most overlooked cost-reduction option in the GLP-1 space. They exist specifically to provide medication access for low-income, uninsured, or underinsured patients who wouldn't otherwise afford brand-name prescriptions. The programs are real, funded by manufacturers for public relations and market access reasons, and genuinely provide free or deeply discounted medication for qualifying patients.

The catch: most patients never hear about them. Providers rarely mention PAPs proactively. Marketing focuses on savings cards and subscription programs instead. This guide covers what's actually available in 2026.

The core programs

Program	Medications Covered	Typical Benefit
Novo Nordisk Patient Assistance Program	Ozempic, Wegovy, Rybelsus, Victoza	Free medication for eligible patients
Lilly Cares Patient Assistance Program	Mounjaro, Zepbound, Trulicity	Free medication for eligible patients
Sanofi Patient Connection	Older GLP-1s, related products	Free medication for eligible patients

Novo Nordisk Patient Assistance Program (NNPAP)

Novo Nordisk's program covers Ozempic, Wegovy, Rybelsus, and several other Novo products. As of 2026, the program has specific criteria:

Eligibility

• Uninsured or underinsured. No private insurance, no Medicare Part D coverage of the medication, or coverage that leaves significant cost.
• Income limitations. Generally 400% of Federal Poverty Level or less (roughly $60K individual, $125K family of four in 2026).
• US resident. Citizenship or legal residency required.
• Medical necessity. Documented prescription from a licensed US provider.
• Not enrolled in other manufacturer programs. Can't stack with Wegovy Savings Card for the same medication.

Application process

1. Download application from NovoCare website or request via provider.
2. Complete patient portion with income documentation.
3. Provider completes medical necessity section.
4. Submit with required documentation (tax return or pay stubs for income verification).
5. Processing time: typically 2–4 weeks.
6. Approved patients receive medication directly shipped, typically 3-month supplies.
7. Re-application required annually.

What you get

• Free Ozempic or Wegovy shipped to you (or your provider's office)
• Full dose as prescribed
• Renewal shipments for ongoing treatment as long as eligibility continues
• No copay, no monthly fees

Lilly Cares Patient Assistance Program

Lilly Cares covers Mounjaro, Zepbound, Trulicity, and other Lilly products. Structure is similar to Novo's but with some differences.

Eligibility

• US resident with prescription from licensed US provider.
• No other prescription drug coverage for the specific medication (Medicaid, Medicare Part D exclusion, commercial insurance denial).
• Income criteria: Typically 400% of FPL or less.
• Not receiving medication through Medicare Extra Help or other subsidy programs.

Application process

1. Apply online at lillycares.com or via paper application.
2. Provider completes portion with medical necessity.
3. Submit income and insurance documentation.
4. Processing time: typically 2–4 weeks.
5. Approved patients receive medication shipments.
6. Annual renewal required.

Savings cards vs. patient assistance programs

Commonly confused, but functionally different:

Feature	Savings Card	Patient Assistance Program
For whom	Commercial insurance patients	Uninsured/underinsured
Income requirements	None typically	Yes (400% FPL or less)
Application complexity	Simple (fill out form)	Documented (income verification)
Benefit	Reduced copay	Free medication
Government insurance?	Explicitly excluded	Explicitly required (for PAP eligibility)
Duration	Usually 12–13 fills maximum	Annual renewal, ongoing

Third-party coordination services

Several nonprofit and for-profit organizations help patients navigate PAP applications:

• NeedyMeds.org: Free comprehensive database of manufacturer PAPs and enrollment assistance.
• RxAssist.org: Similar database with application help.
• RxHope: Online application portal for some programs.
• Local health departments: Many have staff who help low-income patients access PAPs.
• Federally Qualified Health Centers (FQHCs): Have pharmacists and social workers who routinely help with PAP applications.

What to do if you're denied

Initial PAP denials are common but often reversible. Common denial reasons and solutions:

• Income just above threshold: Reapply with updated documentation if your income changes. Consider the FPL calculation methodology — some programs allow deduction for medical expenses.
• "You have insurance coverage": If your insurance denies the medication, appeal your insurance first. If denied at insurance level, reapply to PAP documenting the insurance denial.
• Medical necessity insufficient: Work with your provider to strengthen the clinical documentation.
• Missing paperwork: Complete and resubmit.

Ineligible? Other options

If you don't qualify for PAPs, other cost-reduction options:

• Manufacturer savings cards (for insured patients only).
• Subscription programs (NovoCare, LillyDirect, Novo 12-month Wegovy subscription at $249/mo).
• Compounded alternatives (Yucca $146/mo, MEDVi $179/mo).
• Clinical trials (free medication for study participants).
• HSA/FSA tax advantages (effective 25–37% discount via pre-tax dollars).

Timing considerations

PAP applications take time. Plan accordingly:

• Submit applications 4–6 weeks before needing medication.
• Continue existing treatment during application if possible.
• Set calendar reminders for annual renewals — failure to renew results in medication interruption.
• Keep all documentation for potential audit or reapplication.

Common application mistakes

For patients with Medicaid

Medicaid beneficiaries are typically excluded from manufacturer PAPs because Medicaid is considered prescription drug coverage. However:

• If your state Medicaid doesn't cover the specific GLP-1, PAP eligibility may apply.
• Medicaid spend-down programs can help with costs if medication isn't covered.
• Some state pharmaceutical assistance programs layer on top of Medicaid.

For patients with Medicare

Medicare beneficiaries with Part D coverage are typically excluded from manufacturer PAPs. Exceptions and workarounds:

• Extra Help / Low-Income Subsidy for Medicare Part D can reduce copays substantially.
• Medicare Part B coverage (for some medical devices) may be relevant for some GLP-1 administration scenarios.
• 2027 Medicare negotiated prices will reduce costs even without PAP access.

Bottom line

Patient assistance programs are the best-kept secret in GLP-1 cost reduction for low-income and uninsured patients. Free brand-name medication is genuinely available for qualifying patients, but requires application effort, income documentation, and annual renewal. If you're struggling with GLP-1 costs and don't have commercial insurance coverage, PAP applications should be your first move — not a last resort. Services like NeedyMeds can help navigate the process.